Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

381 evidences · page 10 / 16

1,3 risk_ratioLow breast cancer knowledge was associated with a risk ratio of 1.3 for advanced-stage diagnosis after early breast cancer detection.

Nigeriacancer du seinpublié 2021PloS onePubMeddocument de 6 observations

Albumin/CRP ratio was significantly associated with Subjective Global Assessment (SGA) categories in breast cancer patients (p = 0.002).

Nigeriacancer du seinobservé January and June 2018publié 2022Nutrition and cancerPubMeddocument de 7 observations

40,3 per_1The male-to-female ratio among breast cancer cases was 40.3:1.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations

All breast cancer patients with pathogenic BRCA1/2 variants had triple-negative breast cancer (TNBC) and a family history of cancer.

Nigeriacancer du sein · triple-negative breast cancer (TNBC)publié 2025Technology in cancer research & treatmentPubMeddocument de 2 observations

23,6 %The proportion of metastatic breast cancer cases was 23.6% during 2013–2015.

Nigeriacancer du seinobservé 2013-2015publié 2023West African journal of medicinePubMeddocument de 8 observations

30,4 %Lack of knowledge was reported as a barrier to breast cancer screening by 30.4% of participants.

Nigeriacancer du seinpublié 2023African health sciencesPubMeddocument de 4 observations

65,4 %The majority (65.4%) of the breast cancer patients were premenopausal.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

0,4 %Among all cases, 0.4% carried a loss-of-function mutation in TP53.

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

41,8 %Among 294 Nigerian women with breast cancer who had immunohistochemical analysis, 41.8% were classified as triple-negative breast cancer (TNBC).

Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 9 observations

33,3 %Breast cancer accounted for about a third of cases of pathological nipple discharge.

Nigeriacancer du sein · pathological nipple dischargepublié 2023West African journal of medicinePubMeddocument de 10 observations

49,8 yearsAmong 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, 597 were female, with a mean age of 49.8 ± 12.2 years.

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

50 %The overall five-year survival for breast cancer patients was 50%.

Nigeriacancer du seinpublié 2019The Pan African medical journalPubMeddocument de 7 observations

In Nigeria, access to mammography within 120 minutes ranges from 64.8% to 80.6% between northern and southern regions.

Nigeriacancer du seinpublié 2023JCO global oncologyPubMeddocument de 7 observations

52 monthsThe median survival for breast cancer patients was 52 months.

Nigeriacancer du seinpublié 2019The Pan African medical journalPubMeddocument de 7 observations

72 %72% of the tumors were node positive.

Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873

31 %The hazard of progressing from early to locally advanced breast cancer was 31% in 90 days.

Nigeriacancer du seinobservé June 2017 to May 2018publié 2020BMC public healthPubMeddocument de 9 observations

65,11 %Breast self-examination awareness was 65.11% among female students and staff of six educational institutions in Ota, Southwest Nigeria.

Nigeriacancer du seinpublié 2023African journal of reproductive healthPubMeddocument de 10 observations

40 daysThe median diagnostic interval was 40 days among young adult females with breast cancer in Nigeria.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

2 049 USDThe mean cost of diagnosis and treatment was $2,049 (SD $1,854).

Nigeriacancer du seinpublié 2022The Pan African medical journalPubMeddocument de 9 observations

70,8 %70.8% of breast cancer patients received systemic chemotherapy.

Nigeriacancer du seinobservé May 2009–January 2019publié 2021CancerPubMeddocument de 7 observations

3,7 %Among cases, 3.7% (37 individuals) were classified as high risk using a lifetime absolute risk threshold of 10% or higher in the epidemiologic factors only model.

Nigeriacancer du seinpublié 2025JAMA network openPubMeddocument de 6 observations

0,21 odds_ratioWomen in the highest category of educational attainment had an odds ratio of 0.21 for breast cancer compared to those in the lowest category after adjustments.

Nigeriacancer du seinpublié 2022The Pan African medical journalPubMeddocument de 5 observations

13,7 %13.70% of participants lacked knowledge about the effects of carbonated drink consumption on breast cancer risk.

Nigeriacancer du seinpublié 2024JCO global oncologyPubMeddocument de 12 observations

76 %Among breast cancer cases recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 76% of those detected via health check-ups were assigned to palliative care compared to 58% of those detected clinically.

Nigeriacancer du seinobservé 2016 to 2018publié 2025Cancer causes & control : CCCPubMeddocument de 9 observations

0,21 correlation_coefficientTNF-α correlated with tumor-infiltrating lymphocytes (TILs) (ρ = 0.21; p = 0.026).

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 14 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.